leon nanodrugs

company

About

leon-nanodrugs is a nanotechnology-based drug development company.

  • 11 - 50

Details

Last Funding Type
Series B
Industries
Biotechnology,Health Care,Medical,Pharmaceutical
Founded date
Jan 1, 2011
Number Of Employee
11 - 50
Operating Status
Active

leon nanodrugs a specialised product development company dedicated to developing a pipeline of enhanced versions of existing drug products, and providing services to enable pre-clinical and clinical stage formulations for their clients NCEs or branded established drugs.

leon-nanodrugs offers access to the next generation of nano-formulated drugs with meaningful differentiation and added patient benefits.

They specialize in improving the bioavailability of poorly water soluble drugs by using leon’s proprietary MJR® Technology platform to create either polymeric or crystalline nanoparticles.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
€18.50M
leon nanodrugs has raised a total of €18.50M in funding over 2 rounds. Their latest funding was raised on Apr 16, 2020 from a Series B round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Apr 16, 2020 Series B 3 Detail
Jul 27, 2015 Series A €18.50M 1 Detail

Investors

Number of Lead Investors
Number of Investors
3
leon nanodrugs is funded by 3 investors. Evotec and LOF Leon Partnership are the most recent investors.
Investor Name Lead Investor Funding Round
Evotec Series B
LOF Leon Partnership Series B
Albany Private Equity Holding Series B